5/A//SEC Filing
Immune Therapeutics, Inc. 5/A
Accession 0001611517-16-000002
CIK 0001559356operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:24 PM ET
Size
5.3 KB
Accession
0001611517-16-000002
Insider Transaction Report
Form 5/AAmended
Griffin Noreen
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
COMMON STOCK
2015-12-04$80000.00/sh−1,000,000$80,000,000,000→ 4,317,710 total
Footnotes (2)
- [F1]This transaction was reported on the Form 5 filed on March 30, 2016 but incorrectly identified the price as $50,000 rather than the correct price of $80,000 for 1 million shares ($0.08 per share).
- [F2]This form amends the transaction dated 12/4/15 reported on the Form 5 filed on March 30, 2016.
Documents
Issuer
Immune Therapeutics, Inc.
CIK 0001559356
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001559356
Filing Metadata
- Form type
- 5/A
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:24 PM ET
- Size
- 5.3 KB